Table 2. Post-bronchodilator spirometry results.
| All (n = 195) |
HIV-positive (n = 82) |
HIV-negative (n = 113) | P value | |
|---|---|---|---|---|
| FEV1 (L) | 2.94 (0.79) | 2.62 (0.66) | 3.17 (0.80) | <0.01 |
| FEV1% predicted* | 101.0 (16.3) | 96.4 (17.7) | 104.0 (14.5) | <0.01 |
| FVC (L) | 3.51 (0.81) | 3.22 ((0.71) | 3.73 (0.82) | <0.01 |
| FVC% predicted* | 99.8 (14.5) | 97.4 (15.2) | 101.4(13.8) | 0.05 |
| FEV1/FVC-ratio | 0.84 (0.09) | 0.82 (0.10) | 0.85 (0.08) | 0.03 |
| FEV1/FVC-ratio predicted* | 101.1 (9.9) | 99.3 (12.2) | 102.3 (7.5) | 0.04 |
| FEV1 < 80% predicted* | 16 (8.2%) | 11 (13.4%) | 5 (4.4%) | 0.02 |
| FEV1/FVC < 0.70 | 9 (4.6%) | 6 (7.3%) | 3 (2.7%) | 0.17 |
| FEV1/FVC < LLN* | 11 (5.6%) | 8 (9.8%) | 3 (2.7%) | 0.06 |
FEV1 forced expiratory volume in 1 s; FVC, forced vital capacity; LLN, lower limit of normal
Data in mean (SE) or n(%).
* Based on GLI reference equations “Afro-American”